and development of
new antibiotics and
An interview with Schelto Korf, NADP Alliance Manager
My role at the Netherlands Antibiotic Development Platform (NADP) as Alliance manager is to support academics and companies in finding new partners for collaboration in R&D of antibiotics and alternatives.Read more
On 5 and 6 July the KWR Watercycle Research Institute has hosted a WHO expert meeting meeting for 35 international experts on water and antimicrobial resistant bacteria to write an action plan for the WHO to stop the spread of antibiotic resistance through water. The water sector has a central position in a lot of these processes, allowing them to contribute to the approach to stop the spread of antibiotic resistance.Read more
Action plan treats human and animal health as interconnected
The European commission has launched a plan to tackle antimicrobial resistance through concrete actions, including stricter monitoring of antibiotic use in farm animals, boosting research into epidemiology and reinforcing cooperation with institutions such as the World Health Organization.Read more
The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year. However, outbreaks of resistant strains of bacteria in healthcare institutions are still reported occasionally. This is expected to happen more often in the future, leaving vulnerable people at an increased risk of getting ill. This is shown in the annual NethMap/MARAN report, which contains information about antibiotic use and antimicrobial resistance in the Netherlands for both humans and animals.Read more
The Dutch Ministry of Ministry of Health, Welfare and Sport and NWO Domain TTW have jointly commissioned an ambitious research programme on the development of new antibiotics and alternatives to antibiotics. As a result, we present here the Call for Proposals focusing on ´Novel Antibacterial Compounds and Therapies Antagonizing Resistance’ (NACTAR). The main goal of the programme is to facilitate research and development of new antimicrobial molecules and alternatives to antibiotics, which should become available for the healthcare system for a fair and affordable price.
Only proposals that have taken part in the pre-proposal phase, will be accepted in the full proposal phase. Deadline pre-proposal phase is 27 June, 14:00 hrs.Read more
No Posts Found.